A type III secretion system (T3SS) in pathogenic Yersinia species functions to translocate Yop effectors, which modulate cytokine production and regulate cell death in macrophages. Distinct pathways of T3SS-dependent cell death and caspase-1 activation occur in Yersinia-infected macrophages. One pathway of cell death and caspase-1 activation in macrophages requires the effector YopJ. YopJ is an acetyltransferase that inactivates MAPK kinases and IKKβ to cause TLR4-dependent apoptosis in naïve macrophages. A YopJ isoform in Y. pestis KIM (YopJ(KIM)) has two amino acid substitutions, F177L and K206E, not present in YopJ proteins of Y. pseudotuberculosis and Y. pestis CO92. As compared to other YopJ isoforms, YopJ(KIM) causes increased apoptosis, caspase-1 activation, and secretion of IL-1β in Yersinia-infected macrophages. The molecular basis for increased apoptosis and activation of caspase-1 by YopJ(KIM) in Yersinia-infected macrophages was studied. Site directed mutagenesis showed that the F177L and K206E substitutions in YopJ(KIM) were important for enhanced apoptosis, caspase-1 activation, and IL-1β secretion. As compared to YopJ(CO92), YopJ(KIM) displayed an enhanced capacity to inhibit phosphorylation of IκB-α in macrophages and to bind IKKβ in vitro. YopJ(KIM) also showed a moderately increased ability to inhibit phosphorylation of MAPKs. Increased caspase-1 cleavage and IL-1β secretion occurred in IKKβ-deficient macrophages infected with Y. pestis expressing YopJ(CO92), confirming that the NF-κB pathway can negatively regulate inflammasome activation. K+ efflux, NLRP3 and ASC were important for secretion of IL-1β in response to Y. pestis KIM infection as shown using macrophages lacking inflammasome components or by the addition of exogenous KCl. These data show that caspase-1 is activated in naïve macrophages in response to infection with a pathogen that inhibits IKKβ and MAPK kinases and induces TLR4-dependent apoptosis. This pro-inflammatory form of apoptosis may represent an early innate immune response to highly virulent pathogens such as Y. pestis KIM that have evolved an enhanced ability to inhibit host signaling pathways.
A type III secretion system (T3SS) in pathogenic Yersinia species functions to translocate Yop effectors, which modulate cytokine production and regulate cell death in macrophages. Distinct pathways of T3SS-dependent cell death and caspase-1 activation occur in Yersinia-infected macrophages. One pathway of cell death and caspase-1 activation in macrophages requires the effector YopJ. YopJ is an acetyltransferase that inactivates MAPK kinases and IKKβ to cause TLR4-dependent apoptosis in naïve macrophages. A YopJ isoform in Y. pestis KIM (YopJ(KIM)) has two amino acid substitutions, F177L and K206E, not present in YopJ proteins of Y. pseudotuberculosis and Y. pestis CO92. As compared to other YopJ isoforms, YopJ(KIM) causes increased apoptosis, caspase-1 activation, and secretion of IL-1β in Yersinia-infected macrophages. The molecular basis for increased apoptosis and activation of caspase-1 by YopJ(KIM) in Yersinia-infected macrophages was studied. Site directed mutagenesis showed that the F177L and K206E substitutions in YopJ(KIM) were important for enhanced apoptosis, caspase-1 activation, and IL-1β secretion. As compared to YopJ(CO92), YopJ(KIM) displayed an enhanced capacity to inhibit phosphorylation of IκB-α in macrophages and to bind IKKβ in vitro. YopJ(KIM) also showed a moderately increased ability to inhibit phosphorylation of MAPKs. Increased caspase-1 cleavage and IL-1β secretion occurred in IKKβ-deficient macrophages infected with Y. pestis expressing YopJ(CO92), confirming that the NF-κB pathway can negatively regulate inflammasome activation. K+ efflux, NLRP3 and ASC were important for secretion of IL-1β in response to Y. pestis KIM infection as shown using macrophages lacking inflammasome components or by the addition of exogenous KCl. These data show that caspase-1 is activated in naïve macrophages in response to infection with a pathogen that inhibits IKKβ and MAPK kinases and induces TLR4-dependent apoptosis. This pro-inflammatory form of apoptosis may represent an early innate immune response to highly virulent pathogens such as Y. pestis KIM that have evolved an enhanced ability to inhibit host signaling pathways.
Microbial pathogens encode numerous types of virulence factors that are used to
circumvent or usurp immune responses within cells of their hosts. A protein export
pathway known as the type III secretion system (T3SS) allows Gram-negative bacterial
pathogens to deliver effector proteins into or across the plasma membrane of host
cells, with the goal of co-opting or disrupting eukaryotic signaling pathways [1], [2]. Infection of
macrophages with T3SS-expressing bacterial pathogens commonly causes cytotoxicity in
the host cell, but the mechanisms of cellular demise and the morphological and
immunological characteristics of cell death can be unique for each microbe [3]. Two types of
macrophage death that can be induced by T3SS-expressing pathogens and distinguished
morphologically and immunologically are apoptosis and pyroptosis [4]. Apoptosis is
traditionally associated with a lack of inflammation while pyroptosis is considered
pro-inflammatory [4], [5]. Apoptosis and pyroptosis can also be distinguished
mechanistically by the fact that only the latter mechanism of cell death is
dependent upon the activity of caspase-1, a pro-inflammatory caspase [4], [5]. Recently,
however it has been determined that caspase-1 can be activated in macrophages dying
of apoptosis [6],
[7], [8], indicating that
pathogen-inflicted apoptosis may not be immunologically silent.Caspase-1 is synthesized as a 45 kDa inactive zymogen that is cleaved to generate the
active heterotetramer composed of two p10 and two p20 subunits [9]. Activation of caspase-1
occurs through its recruitment to an inflammasome complex [10], [11], [12]. Activated caspase-1 cleaves
pro-IL-1β and pro-IL-18, and promotes secretion of the mature forms of these
cytokines by a non-conventional pathway. Macrophages dying of pyroptosis therefore
release active forms of IL-1β, and IL-18, which are important cytokines for
protective host responses against several pathogens [5]. In addition, pyroptosis can
release intracellular bacteria from macrophages, allowing for clearance of the
pathogens by neutrophils [13].Inflammasome complexes assemble on a scaffold of NOD-like receptors
(NLRs) [11], [12], [14]. NLRs comprise a family of pattern recognition receptors
(PRRs) that detect cytosolic pathogen-associated molecular patterns (PAMPs) or
infection-associated processes [10], [11], [12]. Well-studied NLR family members include NLRP3 (formerly
NALP3 or Cryopyrin), NLRC4 (formerly IPAF) and NAIP5. NLRP3 in complex with the
adaptor protein ASC induces the activation of caspase-1 in response to a variety of
microbial products as well as endogenous danger signals such as potassium
(K+) efflux or extracellular ATP [10], [11], [12]. NLRC4 recognizes bacterial
flagellin from S. enterica serovar Typhimurium, which is delivered
into macrophages via a T3SS in this pathogen [10], [13], [15], [16], [17]. Another family of PRRs,
the toll-like receptors (TLRs) often function in concert with NLRs to positively
regulate inflammasome activation and function [18]. For example, production of
pro-IL-1β and pro-IL-18 is upregulated by TLR signaling. In addition, production
of NLRP3 is positively regulated by TLR signaling through the NF-κB pathway
[19].In pathogenic Yersinia species, a plasmid-encoded T3SS delivers Yop
effectors into host cells [2], allowing the bacteria to modulate innate immune responses
[20]. The T3SS
is an essential virulence determinant in these pathogens, which cause diseases
ranging from plague (Y. pestis) to enterocolitis (Y.
enterocolitica) and mesenteric lymphadenitis (Y.
pseudotuberculosis). Naïve Yersinia-infected
macrophages undergo apoptosis via a cell death program that requires TLR4-dependent
activation of initiator and executioner caspases and T3SS-mediated delivery of YopJ,
which inhibits expression of anti-apoptotic factors under regulatory control of MAPK
and NF-κB signaling pathways [21], [22], [23], [24]. Inactivation of the NF-κB and MAPK signaling
pathways via YopJ-mediated inhibition of the inhibitor of kappa B kinase beta
(IKKβ) and MAPK kinases (MKKs) is critical for apoptosis of
Yersinia-infected macrophages [23], [25].YopJ is the prototypical member of a family of T3SS effectors that inhibit the
NF-κB pathway [26], [27], [28]. These proteins exhibit homology to CE cysteine proteases
[26]. Evidence
has been obtained that YopJ can function as a deubiquitinase [29], [30], [31]. However, more recent studies
indicate that YopJ has acetyltransferase activity, acetylating Ser and Thr residues
critical for the activation of the MKKs and IKKβ [32], [33], [34]. YopJ is an important virulence
factor in Y. pseudotuberculosis
[21], [35] and Y.
enterocolitica, where it is known as YopP [36].Recently, it has been determined that caspase-1 can be activated in a T3SS-dependent
manner by two distinct pathways in macrophages infected with
Yersinia
[6]. In one
pathway, insertion of channels or pores in the plasma membrane by the T3SS
translocon activates caspase-1 and causes pyroptosis in
Yersinia-infected macrophages [6], [37], [38], [39]. Activation of caspase-1 in
response to the Yersinia T3SS translocon can be counteracted by Yop
effectors including YopE [39] and YopK [6], and therefore this pathway is
inhibited in macrophages infected with wild-type bacteria.A second pathway of caspase-1 activation that occurs in macrophages infected with
wild-type Yersinia is not inhibited by YopE or YopK and requires
YopJ activity [6], [8]. Although caspase-1 is activated in response to YopJ
activity, caspase-1 is not required for YopJ-dependent macrophage apoptosis [6], [8]. A potential
explanation for the ability of YopJ to cause caspase-1 activation came from the work
of Greten et al. [7], who showed that genetic or pharmacological ablation of
IKKβ resulted in apoptosis, activation of caspase-1 and secretion of IL-1β
from macrophages following stimulation of TLR4 with LPS. Evidence was obtained that
an anti-apoptosis gene product expressed under control of NF-κB, plasminogen
activator inhibitor 2 (PAI-2), negatively regulates apoptosis and caspase-1
activation in LPS-stimulated macrophages [7]. The authors suggested that
inhibition of caspase-1 by the NF-κB pathway represents a negative feedback loop
that allows the innate immune system to activate, via TLR4, a compensatory host
defense response against Gram-negative pathogens that inhibit activation of
NF-κB [7].Different Yersinia strains display a range of YopJ-dependent
apoptotic activities on macrophages [8], [35], [40], [41]. This difference in apoptotic activity is due to the
expression of distinct YopJ isoforms by different Yersinia strains
[8], [35], [40], [41]. For
example, a Y. enterocolitica strain encoding a YopP protein with an
Arg at position 143 was shown to have higher apoptotic activity and inhibit IKKβ
more efficiently in macrophages then strains having a Ser at this position [40].
Y. pestis KIM, a 2.MED (Mediaevalis) biovar strain, encodes a
YopJ isoform that causes higher levels of apoptosis and caspase-1 activation in
infected macrophages as compared to other YopJ isoforms [8]. The YopJKIM protein
has an Arg at position 143 but in addition has two amino acid substitutions, at
positions 177 and 206, as compared to other isoforms of this effector found in
Y. pestis or Y. pseudotuberculosis
strains.Here, the molecular basis for the enhanced ability of YopJKIM to cause
apoptosis and activate caspase-1 in Yersinia-infected macrophages
was studied, with the goal of better understanding the underlying mechanism of this
host response. Analysis of YopJKIM in parallel with other YopJ isoforms
indicated that the unique capacity of this effector to cause high-level apoptosis
and caspase-1 activation requires both codon substitutions at positions 177 and 206.
The presence of these codon substitutions also correlated with the enhanced ability
of YopJKIM to inhibit MKK and IKKβ signaling pathways. Infection of
IKKβ-deficient macrophages with Y. pestis confirmed that this
kinase has an important role in negatively regulating caspase-1 activation [7]. Finally,
evidence was obtained that K+ efflux leading to activation of the
NLRP3/ASC/capsase-1 inflammasome is important for secretion of IL-1β and IL-18
from macrophages infected with Y. pestis KIM. These findings
indicate that, by inhibiting production of survival factors under control of the
NF-κB and MAPK pathways, YopJ causes TLR4-dependent apoptosis and caspase-1
activation in macrophages infected with Yersinia. In addition,
Y. pestis KIM causes high levels of apoptosis and caspase-1
activation in macrophages because it has evolved a YopJ isoform with enhanced
inhibitory activity on NF-κB and MAPK pathways.
Results
Identification of amino acid substitutions in YopJ that increase MyD88- and
Trif-dependent caspase-1 activation in Yersinia-infected
macrophages
Sequence comparisons were made between YopJKIM and YopJ proteins from
two other Yersinia strains that display lower apoptosis
activity in macrophages, Y. pseudotuberculosis IP2666 and
Y. pestis CO92. There is one amino acid difference between
YopJKIM and YopJ in Y. pseudotuberculosis
(YopJYPTB), corresponding to L177F in the predicted catalytic
core [29] of the
enzyme (residues 109-194; Figure S1 in Text S1). Comparison of YopJKIM
with YopJ from Y. pestis CO92 (YopJCO92) revealed
two differences, L177F and E206K, the latter of which is located just beyond the
carboxy-terminal end of the predicted catalytic core (Figure S1 in Text
S1).To determine if the amino acid substitutions at positions 177 and 206 of
YopJKIM affect secretion or delivery of the effector into
macrophages, expression plasmids encoding YopJKIM,
YopJYPTB, or YopJCO92 appended with C-terminal GSK
tags were constructed. An expression plasmid encoding a YopJ isoform with a Leu
at position 177 and a Lys at position 206 (YopJKIME206K) was also
constructed in the same manner. The expression plasmids were introduced into a
ΔyopJ mutant of Y. pseudotuberculosis
(IP26; Table S1 in Text S1). Y.
pseudotuberculosis was used in the experiment because it lacks the
Pla protease of Y. pestis which is known to degrade Yops
secreted in vitro [42]. The resulting strains were induced to secrete Yops
under low calcium growth conditions and immunoblotting of the secreted proteins
showed that YopJKIM, YopJYPTB, YopJKIME206K and
YopJCO92 were exported at equal levels (Figure S2 in Text
S1).A translocation assay was performed using the phospho-GSK reporter system [43]. IP26
strains expressing the different YopJ isoforms fused to GSK were used to infect
bone marrow derived macrophages (BMDMs) for 2 hr. Delivery of the effector into
host cells was measured by anti-phospho-GSK immunoblotting [43]. The results showed that
YopJKIM, YopJYPTB, YopJKIME206K and
YopJCO92 isoforms were translocated at similar levels (Figure 1A). Samples of the
same lysates analyzed in Figure
1A were subjected to immunoblotting with anti-caspase-1 antibody to
measure the level of caspase-1 cleavage. Consistent with previous results [6], cleavage
of caspase-1 was detected in BMDMs infected with Y.
pseudotuberculosis expressing YopJYPTB (Figure 1B, lane 2). However,
caspase-1 cleavage was comparatively higher with expression of
YopJKIM (lane 1) and lower with expression of
YopJKIME206K or YopJCO92 isoforms (lanes 3 and 4,
respectively). These results suggest that the ability of YopJKIM to
trigger maximal caspase-1 activation requires both the F177L and K206E
substitutions, and these codon changes impart an activity to the protein that is
manifested following its delivery into the host cell.
Figure 1
Translocation of different YopJ isoforms and caspase-1 activation in
macrophages infected with Y.
pseudotuberculosis.
Y. pseudotuberculosis IP26
(IP2666ΔyopJ) carrying no pBAD plasmid as a
control (CTL; lane 5) or pBAD vectors encoding the indicated YopJ-GSK
isoforms (lanes 1–4), were grown under T3SS-inducing conditions in
the presence of 0.2% of arabinose. Bacteria were added to BMDMs
at an MOI of 20 and were allowed to infect for 2 hr. Arabinose
(0.2%) was maintained in cell culture medium. Detergent lysates
of infected macrophages were separated by SDS-PAGE and immunoblotting
was performed with anti-phospho-GSK-3® antibody (A) and
anti-caspase-1 antibody (B). Positions of molecular weight standards
(kDa) are shown on the left and positions of YopJ- phospho-GSK and
cleaved caspase-1 are shown on the right.
Translocation of different YopJ isoforms and caspase-1 activation in
macrophages infected with Y.
pseudotuberculosis.
Y. pseudotuberculosis IP26
(IP2666ΔyopJ) carrying no pBAD plasmid as a
control (CTL; lane 5) or pBAD vectors encoding the indicated YopJ-GSK
isoforms (lanes 1–4), were grown under T3SS-inducing conditions in
the presence of 0.2% of arabinose. Bacteria were added to BMDMs
at an MOI of 20 and were allowed to infect for 2 hr. Arabinose
(0.2%) was maintained in cell culture medium. Detergent lysates
of infected macrophages were separated by SDS-PAGE and immunoblotting
was performed with anti-phospho-GSK-3® antibody (A) and
anti-caspase-1 antibody (B). Positions of molecular weight standards
(kDa) are shown on the left and positions of YopJ- phospho-GSK and
cleaved caspase-1 are shown on the right.YopJ-mediated apoptosis in response to Yersinia infection
requires stimulation of TLR4 in naïve macrophages to activate a death
response pathway [25], [44]. It is not known if TLR signaling is required for
YopJ-dependent activation of caspase-1 in Yersinia-infected
macrophages. When BMDMs lacking the two major TLR adaptors, MyD88 and Trif, were
infected with wild-type Y. pseudotuberculosis IP2666 for 2 hr,
activation of caspase-1 was substantially reduced (Figure S3 in Text S1).
Cleavage of caspase-1 was not diminished in IP2666-infected BMDMs missing only
MyD88 or Trif (data not shown), indicating that TLR signaling through either of
these adaptors is important for the downstream events that lead to activation of
caspase-1 in conjunction with YopJ activity. YopJ-dependent caspase-1 activation
and IL-1β secretion were inhibited when BMDMs were treated with LPS prior to
infection with Y. pseudotuberculosis (Figure S3 in Text S1)
[6] or
Y. pestis
[8]. Thus,
macrophages pre-stimulated with LPS are desensitized to undergo YopJ-dependent
apoptosis [38] and caspase-1 activation upon
Yersinia infection. Desensitization occurs because the TLR4
signaling pathway contains a negative feed back mechanism operating via
NF-κB that upregulates expression of proteins that inhibit apoptosis and
activation of caspase-1 [7].
The F177L and K206E substitutions in YopJKIM are important for
increased apoptosis and secretion of IL-1β and IL-18 in Y.
pestis-infected macrophages
To demonstrate that the polymorphisms in YopJKIM at positions 177 and
206 were important for the activity of this effector in the native context of
Y. pestis, a L177F codon change was introduced into the
sequence of yopJ on the virulence plasmid pCD1 by
allelic exchange, converting it to yopJ. In
addition, an E206K codon change, a double L177F/E206K codon change, and a C172A
codon change were introduced into pCD1, creating
yopJ, and
yopJ, respectively. The resulting
strains (referred to as Yp-YopJYPTB, Yp-YopJKIME206K,
Yp-YopJC092 and Yp-YopJC172A)(Table S1 in Text S1)
were phenotypically analyzed. As shown by immunoblotting of whole bacterial
lysates, YopJKIM, YopJYPTB, YopJKIME206K and
YopJCO92 were expressed at equal levels in Y.
pestis (Figure S4 in Text S1). The ability of Y.
pestis strains expressing the different YopJ isoforms to induce
apoptosis and cytokine secretion in BMDMs was then determined after a 24 hr
infection. As shown in Figure
2A,B, the amounts of lactate dehydrogenase (LDH) released (used as a
marker of cell death) and IL-1β secreted were significantly lower in
macrophages infected with Yp-YopJYPTB, Yp-YopJKIME206K or
Yp-YopJCO92 as compared to Yp-YopJKIM. A similar trend
was seen for secretion of IL-18 (Figure 2C).
Figure 2
Cytokine secretion and cell death in macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
BMDMs were left uninfected (U), or infected with the indicated Yp-YopJ
strains at an MOI of 10. Supernatants collected after 24 hr of infection
were used to measure cell death by LDH release (A) and secretion of
IL-1β (B), IL-18 (C) and TNF-α (D) by ELISA. Results shown are
the average of three independent experiments. Error bars represent
standard deviation. Bracketing indicates P values (ANOVA) between
different conditions.
Cytokine secretion and cell death in macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
BMDMs were left uninfected (U), or infected with the indicated Yp-YopJ
strains at an MOI of 10. Supernatants collected after 24 hr of infection
were used to measure cell death by LDH release (A) and secretion of
IL-1β (B), IL-18 (C) and TNF-α (D) by ELISA. Results shown are
the average of three independent experiments. Error bars represent
standard deviation. Bracketing indicates P values (ANOVA) between
different conditions.Caspase-1 was required for the processing and release of IL-1β from
macrophages under these infection conditions as shown by infecting wild-type or
casp-1
-/- BMDMs with Yp-YopJKIM and
isolating IL-1β from infection supernatants by immunoprecipitation. Mature
IL-1β was absent in supernatants isolated from
casp-1
-/- BMDMs infected with
Yp-YopJKIM (Figure S5 in Text S1), indicating that the processing and
release of IL-1β during infection of wild-type macrophages with
Yp-YopJKIM occurred in a caspase-1-dependent manner.As a control, levels of TNF-α, which is secreted independent of caspase-1
activity, were measured. Macrophages infected with Yp-YopJC172A or
Yp-YopJCO92 secreted significantly higher levels of TNF-α as
compared to Yp-YopJKIM, whereas the other mutants tested produced
intermediate results (Figure
2D). Overall, these results indicate that amino acid substitutions at
positions 177 and 206 are important for the ability of YopJKIM to
induce high levels of macrophage apoptosis, caspase-1 activation and secretion
of mature IL-1β and IL-18 in Y. pestis-infected
macrophages. Conversely, the amino acid substitutions at positions 177 and 206
are important for the ability of YopJKIM to inhibit TNF-α
secretion in macrophages under the same conditions.
YopJKIM binds to IKKβ with higher affinity and more
efficiently inhibits phosphorylation of IκBα as compared to
YopJCO92
To determine if YopJKIM has higher affinity for IKKβ as compared
to other YopJ isoforms, several different YopJ proteins were assayed for the
ability to bind this kinase in cell lysates. Purified GST-YopJ fusion proteins
or GST alone bound to beads were incubated in HEK293T cell lysates that
contained overexpressed IKKβ. The amounts of IKKβ and GST proteins
recovered on the beads after washing was measured by quantitative
immunoblotting. IKKβ bound to beads coated with GST-YopJKIM but
not to beads coated with GST alone (Figure 3A, compare lanes 2 and 3). There was reduced binding of
IKKβ to GST-YopJCO92 as compared to GST-YopJKIM (Figure 3A, compare lanes 3 and
5). When the amount of bound IKKβ was normalized to the amount of GST fusion
protein recovered, it was estimated that 10-times less IKKβ bound to
GST-YopJCO92 as compared to GST-YopJKIM (Figure 3B). A GST fusion
protein encoding YopJC172A bound ∼5 times less IKKβ as
compared to GST-YopJKIM (Figure 3A, compare lanes 3 and 4, Figure 3B), suggesting that the catalytic Cys
residue contributes to binding between IKKβ and YopJKIM. Overall,
these results suggest that YopJKIM has higher affinity for IKKβ
as compared to YopJCO92.
Figure 3
Measurement of IKKβ binding to different YopJ isoforms and
phospho-IκBα levels in macrophages infected with different
Y. pestis strains.
(A) Binding of IKKβ to different YopJ isoforms as determined using a
GST pull down procedure and lysates of transfected HEK293T cells.
Purified proteins corresponding to GST (lane 2) or the indicated
GST-YopJ fusion proteins (lanes 3–5) were immobilized on beads and
incubated in cell lysates containing overexpressed IKKβ. After
washing, proteins bound to the beads were detected and the signals
quantified by immunoblotting using antibodies to IKKβ or GST and an
Odyssey imaging system. Lane 1 contains a sample of the input
transfected cell lysate (Input). Positions of molecular weight standards
(kDa) are shown on the left and positions of IKKβ, GST-YopJ, and GST
proteins are shown on the right. (B) Ratios of the signals for IKKβ
and GST obtained by immunoblotting are presented in bar graph format,
with values representing averages of two independent experiments. (C)
BMDMs were left uninfected (U) or infected with Yp-YopJKIM,
Yp-YopJC172A or Yp-YopJCO92 at an MOI of 50.
At 1 hr post infection lysates of the infected macrophages were prepared
and subjected to ELISA to determine levels of phospho (p)-IκBα.
Results show p-IκBα values normalized to arbitrary units by
setting uninfected to 1. Results were averaged from six (uninfected and
Yp-YopJKIM) or three (Yp-YopJC172A and
Yp-YopJCO92) independent experiments and error bars
represent standard deviations. P value<0.05 (t test) as compared to
Yp-YopJKIM condition is indicated by (*).
Measurement of IKKβ binding to different YopJ isoforms and
phospho-IκBα levels in macrophages infected with different
Y. pestis strains.
(A) Binding of IKKβ to different YopJ isoforms as determined using a
GST pull down procedure and lysates of transfected HEK293T cells.
Purified proteins corresponding to GST (lane 2) or the indicated
GST-YopJ fusion proteins (lanes 3–5) were immobilized on beads and
incubated in cell lysates containing overexpressed IKKβ. After
washing, proteins bound to the beads were detected and the signals
quantified by immunoblotting using antibodies to IKKβ or GST and an
Odyssey imaging system. Lane 1 contains a sample of the input
transfected cell lysate (Input). Positions of molecular weight standards
(kDa) are shown on the left and positions of IKKβ, GST-YopJ, and GST
proteins are shown on the right. (B) Ratios of the signals for IKKβ
and GST obtained by immunoblotting are presented in bar graph format,
with values representing averages of two independent experiments. (C)
BMDMs were left uninfected (U) or infected with Yp-YopJKIM,
Yp-YopJC172A or Yp-YopJCO92 at an MOI of 50.
At 1 hr post infection lysates of the infected macrophages were prepared
and subjected to ELISA to determine levels of phospho (p)-IκBα.
Results show p-IκBα values normalized to arbitrary units by
setting uninfected to 1. Results were averaged from six (uninfected and
Yp-YopJKIM) or three (Yp-YopJC172A and
Yp-YopJCO92) independent experiments and error bars
represent standard deviations. P value<0.05 (t test) as compared to
Yp-YopJKIM condition is indicated by (*).To determine if YopJKIM is a better inhibitor of IKKβ than
YopJCO92, the amount of phosphorylated IκBα
(p-IκBα) in BMDMs was measured after a 1 hr infection. As shown in Figure 3C, significantly lower
levels of p-IκBα were present in macrophages infected with
Yp-YopJKIM as compared to BMDMs infected with
Yp-YopJCO92. In addition, significantly lower levels of
p-IκBα were present in macrophages infected with Yp-YopJKIM
as compared to BMDMs infected with Yp-YopJC172A (Fig. 3C), confirming that acetyltransferase
activity is important for YopJ to inhibit the NF-κB pathway. Because
IκBα is directly phosphorylated by IKKβ, these results are
consistent with the idea that YopJKIM more efficiently inhibits
IKKβ activity as compared to YopJCO92.
Partial genetic ablation of IKKβ increases caspase-1 activation in
Y. pestis-infected macrophages
Greten et al. have shown that treatment of IKKβ-deficient macrophages with
LPS causes activation of caspase-1 and secretion of IL-1β [7]. If IKKβ
activity is important to suppress activation of the inflammasome in macrophages
infected with a live Gram-negative pathogen, than increased caspase-1 activation
and IL-1β secretion should be observed in IKKβ-deficient as compared to
wild-type BMDMs infected with Y. pestis. The effect of genetic
inactivation of Ikkβ on caspase-1 activation in Y.
pestis-infected macrophages was therefore investigated.
IKKβ-deficient BMDMs were generated by conditional Cre-lox-mediated deletion
of a “floxed” Ikkβ gene (referred to as
IkkβΔ BMDMs; Materials and Methods). The
IkkβΔ BMDMs or wild-type control
IkkβF/F macrophages were left uninfected or
infected with Yp-YopJKIM,
Yp-YopJCO92 or
Yp-YopJC172A for 4 hr. Quantitative RT-PCR
(qRT-PCR) of Ikkβ message was used to estimate the
efficiency of Cre-lox mediated deletion of the Ikkβ gene in
the BMDMs. Results indicated that ∼50% of the
Ikkβ genes had been deleted in the population of
IkkβΔ cells (Figure S6A in Text S1).
The impact of this partial deficiency in Ikkβ on the
expression and secretion of cytokines in the Y. pestis infected
macrophages was determined. As compared to the
IkkβF/F macrophages, the
IkkβΔ BMDMs were compromised for
infection-induced expression of mRNA for the cytokines IL-18, TNFα and
IL-1β, as shown by qRT-PCR (Figure S6B–D in Text S1).
This result was expected since the NF-κB pathway positively regulates
expression the il-18, tnf and il-1b genes. Accordingly, the
IkkβΔ BMDMs secreted lower levels of
TNFα as compared to IkkβF/F macrophages
after a 24 hr infection (Figure
4A). In addition, during infection with Yp-YopJCO92 or
Yp-YopJC172A, higher amounts of IL-1β were secreted from
IkkβΔ BMDMs as compared to
IkkβF/F macrophages (Figure 4B), consistent with the idea that the
NF-κB pathway negatively regulates processing and secretion of IL-1β via
control of caspase-1 activation [7]. Unexpectedly, the amount of IL-1β secreted
following infection with Yp-YopJKIM appeared to be lower in
IkkβΔ BMDMs as compared to
IkkβF/F macrophages, although the observed
difference was not statistically significant (Figure 4B). The interpretation of this latter
result was complicated because of the fact that there was only partial
deficiency in Ikkβ in the
IkkβΔ BMDMs, but one possible
explanation was that synthesis of pro-IL-1β was reduced due to the extremely
low level il-1b message in the IkkβΔ BMDMs
infected with Yp-YopJKIM (Figure S6D in Text
S1).
Figure 4
IL-1β and TNF-α secretion in
IkkβF/F or
IkkβΔ macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
IkkβF/F or
Ikkβ
macrophages were left uninfected (U) or infected with the indicated
Yp-YopJ strains at an MOI of 10. Twenty-four hr post infection, cell
supernatants were collected. Secreted TNF-α (A) and IL-1β (B)
were measured by ELISA. Results were averaged from three independent
experiments, and error bars represent standard deviation. P values (t
test) are indicated by bracketing (P<0.05 (*), P<0.01
(**), P<0.001(***).
IL-1β and TNF-α secretion in
IkkβF/F or
IkkβΔ macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
IkkβF/F or
Ikkβ
macrophages were left uninfected (U) or infected with the indicated
Yp-YopJ strains at an MOI of 10. Twenty-four hr post infection, cell
supernatants were collected. Secreted TNF-α (A) and IL-1β (B)
were measured by ELISA. Results were averaged from three independent
experiments, and error bars represent standard deviation. P values (t
test) are indicated by bracketing (P<0.05 (*), P<0.01
(**), P<0.001(***).Activation of caspase-1 was measured by immunoblotting to detect the cleaved
enzyme in lysates prepared 2 hr after infection of
IkkβΔ or
IkkβF/F BMDMs with Yp-YopJKIM,
Yp-YopJCO92 or Yp-YopJC172A. Caspase-1 activation in
uninfected BMDMs or in macrophages treated with LPS and ATP was determined in
parallel for comparison. Increased caspase-1 cleavage occured in
IkkβΔ macrophages infected with
Yp-YopJKIM or Yp-YopJCO92 as compared to
IkkβF/F BMDMs infected with the same strains
(Figure 5A, compare
lanes 7 and 8 with 2 and 3). Cleaved caspase-1 was below the limit of detection
in IkkβΔ macrophages infected with
Yp-YopJC172A (Figure
5A, lane 9). Activation of caspase-1 was also measured by a
microscopic assay utilizing FAM-YVAD-FMK, a fluorescent probe for active
caspase-1, in IkkβΔ or
IkkβF/F BMDMs infected for 9 hr. The results
showed overall higher levels of caspase-1 positive cells in
IkkβΔ as compared to
IkkβF/F macrophages (Figure 5B and C). Taken together, these
results show that loss of IKKβ activity can increase caspase-1 activation in
macrophages infected with Y. pestis, and are consistent with
the idea that IKKβ is an important target of YopJ for activation of the
inflammasome.
Figure 5
Caspase-1 activation in IkkβF/F or
IkkβΔ macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
IkkβF/F or
Ikkβ BMDMs
were left uninfected (U) or infected with the indicated Yp-YopJ strains
at an MOI of 20 (A) or 10 (B and C), or treated with LPS for 3 hr and
then exposed to ATP (LPS/ATP). (A) Caspase-1 cleavage was determined at
1 hr post ATP treatment or 2 hr post infection. In (A) samples of
detergent lysates were separated by SDS-PAGE and immunoblotted with
anti-caspase-1 antibody (upper panel) or anti-actin antibody antibody
(lower panel). Positions of molecular weight standards (kDa) are shown
on the left and positions of cleaved caspase-1 and actin are shown on
the right. In (B) uninfected or infected macrophages on coverslips were
incubated with FLICA reagent (FAM-YVAD-FMK) at 9 hr post infection to
stain for active caspase-1 (green fluorescence). The samples were fixed,
mounted on slides, and light microscopy was used to detect phase
(a–d, i–l) or fluorescence (e-h, m-p) signals.
Representative images of uninfected or infected cells were captured by
digital photomicroscopy. White arrows point to FLICA positive cells. In
(C), average percentages (error bars show standard deviation) of FLICA
positive cells counted from three random fields per coverslip in three
independent experiments is shown. P values comparing results of
infection in Ikkβ to
IkkβF/F BMDMs was determined
(P<0.01, **; P<0.001, ***).
Caspase-1 activation in IkkβF/F or
IkkβΔ macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
IkkβF/F or
Ikkβ BMDMs
were left uninfected (U) or infected with the indicated Yp-YopJ strains
at an MOI of 20 (A) or 10 (B and C), or treated with LPS for 3 hr and
then exposed to ATP (LPS/ATP). (A) Caspase-1 cleavage was determined at
1 hr post ATP treatment or 2 hr post infection. In (A) samples of
detergent lysates were separated by SDS-PAGE and immunoblotted with
anti-caspase-1 antibody (upper panel) or anti-actin antibody antibody
(lower panel). Positions of molecular weight standards (kDa) are shown
on the left and positions of cleaved caspase-1 and actin are shown on
the right. In (B) uninfected or infected macrophages on coverslips were
incubated with FLICA reagent (FAM-YVAD-FMK) at 9 hr post infection to
stain for active caspase-1 (green fluorescence). The samples were fixed,
mounted on slides, and light microscopy was used to detect phase
(a–d, i–l) or fluorescence (e-h, m-p) signals.
Representative images of uninfected or infected cells were captured by
digital photomicroscopy. White arrows point to FLICA positive cells. In
(C), average percentages (error bars show standard deviation) of FLICA
positive cells counted from three random fields per coverslip in three
independent experiments is shown. P values comparing results of
infection in Ikkβ to
IkkβF/F BMDMs was determined
(P<0.01, **; P<0.001, ***).
YopJKIM more efficiently inhibits activation of MAPKs as compared
to YopJCO92
In addition to binding to and acetylating IKKβ, YopJ binds to and acetylates
other members of the MKK superfamily including MKK1, MKK2, MKK3, MKK4, MKK5, and
MKK6 [26], [32], [33]. There is
evidence that YopJ binds to a site conserved on members of the MKK-IKK
superfamily [45].
Since we had previously obtained evidence that inhibition of MAPK signaling was
critical for YopJ-induced macrophage apoptosis [23], we sought to determine if
YopJKIM could more efficiently inhibit MAPK phosphorylation as
compared to YopJCO92. BMDMs were left uninfected or infected for 30
or 60 min with Yp-YopJKIM, Yp-YopJCO92,
or Yp-YopJC172A and ELISA was used to measure
phosphorylation of the MAPKs ERK (substrate of MKK1/2), p38 (substrate of
MKK3/6) and SAPK/JNK (substrate of MKK4/7) (Materials and Methods). As shown in Figure 6A, ERK was not phosphorylated to a
large degree at either time point in macrophages infected with
Yp-YopJC172A and therefore it was not possible
to evaluate the degree to which ERK phosphorylation was inhibited by either
YopJKIM or Yp-YopJCO92. In contrast, p38 and JNK did
show increased phosphorylation upon infection with
Yp-YopJC172A, especially at the 30 min time
point (Figure 6B and C,
respectively). There was in general reduced phosphorylation of p38 and JNK in
BMDMs infected with Yp-YopJKIM as compared to YopJCO92,
especially at the 30 min time point, and the difference was statistically
significant in the case of JNK (Figure 6B and C). These results suggest that YopJKIM more
efficiently inhibits the activities of MKK3/6 and MKK4/7 as compared to
YopJCO92.
Figure 6
Measurement of phospho-MAPK levels in macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
BMDMs were left uninfected (U), or infected with the indicated Yp-YopJ
strains at an MOI of 20. At 30 or 60 min post infection lysates of the
infected macrophages were prepared and subjected to ELISA to determine
levels of phospho-ERK (A), -p38 (B) or –SAPK/JNK (C). Results show
OD450 values averaged from three (uninfected, Yp-YopJKIM and
Yp-YopJCO92) or two (Yp-YopJC172A) independent
experiments and error bars represent standard deviations. P value
(*, <0.05) (t test) is indicated by bracket.
Measurement of phospho-MAPK levels in macrophages infected with
Y. pestis strains expressing different YopJ
isoforms.
BMDMs were left uninfected (U), or infected with the indicated Yp-YopJ
strains at an MOI of 20. At 30 or 60 min post infection lysates of the
infected macrophages were prepared and subjected to ELISA to determine
levels of phospho-ERK (A), -p38 (B) or –SAPK/JNK (C). Results show
OD450 values averaged from three (uninfected, Yp-YopJKIM and
Yp-YopJCO92) or two (Yp-YopJC172A) independent
experiments and error bars represent standard deviations. P value
(*, <0.05) (t test) is indicated by bracket.
The NLRP3/ASC/caspase-1 inflammasome is important for secretion of IL-1β
and IL-18 from macrophages infected with Yp-YopJKIM
The importance of several different inflammasome components for Y.
pestis-induced secretion of IL-1β and IL-18 was investigated
using NLRP3 (Nlrp3-/-)-, ASC (Asc-/-)- or NLRC4
(Nlrc4-/-)-deficient BMDMs. The mutant BMDMs or wild-type control
macrophages were infected with Yp-YopJKIM or Yp-YopJC172A.
Tissue culture supernatants were collected and analyzed by ELISA to measure the
levels of IL-1β and IL-18 present after 24 hr of infection. NLRP3- or
ASC-deficient BMDMs infected with Yp-YopJKIM secreted significantly
lower levels of IL-1β and IL-18 as compared to wild-type macrophages
infected with Yp-YopJKIM (Figure 7A,B; Figure S7A, B in Text S1).
NLRC4-deficient macrophages released similar levels of these cytokines as
compared to wild-type BMDMs (Figure
7A, Figure S7A in Text S1), suggesting that NLRC4 does not play
a significant role in caspase-1 activation and cytokine secretion during
Yp-YopJKIM infection. Both Yp-YopJKIM and
Yp-YopJC172A stimulated infected BMDMs to secrete TNF-α,
although higher levels (∼2 to 3 fold) of TNF-α were secreted from
macrophages infected with Yp-YopJC172A regardless of macrophage type
infected (Figure 7C, D).
Thus, NLRP3 and ASC, but not NLRC4, are involved in the secretion of IL-1β
and IL-18, but not TNF-α, from Yp-YopJKIM -infected
macrophages.
Figure 7
Determination of the importance of inflammasome components for
cytokine secretion and cell death in infected macrophages.
Wild-type BMDMs, or BMDMs deficient for NLRC4 (Ipaf), ASC (ASC) or NLRP3
(Nalp3) were left uninfected (U) or infected with Yp-YopJKIM
or Yp-YopJC172A at an MOI of 10. Supernatants were collected
at 24 hr post-infection and analyzed by ELISA to quantify amounts of
secreted IL-1β (A, B) or TNF-α (C, D). Cell death was measured
by LDH release (E, F). Results shown are the average of three
independent experiments. Error bars represent standard deviation.
Statistical significance compared to YP-YopJKIM-infected
wild-type BMDMs was determined (ANOVA; P<0.05, *; P<0.01,
**).
Determination of the importance of inflammasome components for
cytokine secretion and cell death in infected macrophages.
Wild-type BMDMs, or BMDMs deficient for NLRC4 (Ipaf), ASC (ASC) or NLRP3
(Nalp3) were left uninfected (U) or infected with Yp-YopJKIM
or Yp-YopJC172A at an MOI of 10. Supernatants were collected
at 24 hr post-infection and analyzed by ELISA to quantify amounts of
secreted IL-1β (A, B) or TNF-α (C, D). Cell death was measured
by LDH release (E, F). Results shown are the average of three
independent experiments. Error bars represent standard deviation.
Statistical significance compared to YP-YopJKIM-infected
wild-type BMDMs was determined (ANOVA; P<0.05, *; P<0.01,
**).
YopJKIM-induced macrophage apoptosis does not require NLRP3, ASC
or NLRC4
To determine if NLRP3, NLRC4 or ASC play a role in YopJKIM-dependent
apoptosis, wild-type BMDMs or BMDMs deficient for these inflammasome components
were left uninfected or infected with Yp-YopJKIM or
Yp-YopJC172A. Tissue culture supernatants were collected 24 hr
post-infection and analyzed for LDH. Similar levels of LDH were released from
NLRP3, NLRC4 or ASC-deficient BMDMs as compared wild-type macrophages after
Yp-YopJKIM infection (Figure 7E, F). Low levels of LDH release
occurred in all macrophages infected with Yp-YopJC172A. These results
demonstrate that apoptosis can occur in Yp-YopJKIM -infected
macrophages in the absence of NLRP3, NLRC4 or ASC, consistent with our previous
data showing that macrophage apoptosis during Yp-YopJKIM infection is
independent of caspase-1 [8].
Evidence that K+ efflux is important for secretion of
IL-1β and IL-18 from macrophages infected with Yp-YopJKIM
Efflux of intracellular K+ has been implicated in the activation
of the NLRP3/ASC/caspase-1 inflammasome [10], [11], [12]. To assess a role for
intracellular K+ efflux in caspase-1 activation and IL-1β
release during infection with Y. pestis, BMDMs were infected
with Yp-YopJKIM or Yp-YopJC172A, and then incubated in
cell culture media supplemented with 30 mM KCl, 30 mM NaCl or no supplement.
Cell culture supernatants were collected at 8 hr and 24 hr time points and
analyzed for the presence of IL-1β and TNF-α by ELISA. Significantly
lower levels of IL-1β (∼5-fold) were secreted from macrophages infected
with Yp-YopJKIM in the presence of 30 mM KCl as compared to untreated
macrophages at 8 hr post-infection (Figure 8A). Macrophages infected with Yp-YopJKIM in the
presence of 30 mM NaCl appeared to secrete IL-1β to slightly lower levels as
compared to untreated infected macrophages at 8 hr post-infection, but this
difference was not significant (Figure 8A). A similar trend of IL-1β secretion was observed at
the 24 hr time point when macrophages were infected with Yp-YopJKIM
in the presence or absence of KCl or NaCl (Figure 8C). Macrophages infected with
Yp-YopJC172A secreted similar low levels of IL-1β regardless
of treatment (Figure 8A, C).
Secretion of TNF-α from Yp-YopJKIM- or
Yp-YopJC172A-infected macrophages was not affected by the presence of
30 mM KCl or NaCl (Figure 8B,
D). In addition, the presence of 30 mM KCl did not diminish LDH
release from BMDMs infected with Yp-YopJKIM (data not shown). BMDMs
deficient for the purinergic receptor, P2X7, secreted similar levels
of IL-1β and IL-18 as did wild-type macrophages infected with
Yp-YopJKIM, indicating that this receptor does not play a
significant role in inducing the secretion of these cytokines (data not shown).
Taken together, these results suggest that a K+ efflux that
occurs independent of P2X7R is important for activation of the
NLRP3/ASC/caspase-1 inflammasome in macrophages infected with
Yp-YopJKIM.
Figure 8
Determination of the effect of exogenous KCl on cytokine expression
and secretion in infected macrophages.
BMDMs were left uninfected (U) or infected at an MOI of 10 with
Yp-YopJKIM or Yp-YopJC172A and treated with 30
mM KCl (K+), 30 mM NaCl (Na+) or left untreated (Media) as
indicated. Supernatants were collected at 8 hr (A, B) or 24 hr (C, D)
post-infection, and secreted IL-1β (A, C) and TNF-α (B, D) were
measured by ELISA. (E) Pro-IL-1β in cell lysates prepared at 8 hr
post-infection was detected by immunoblotting with anti-IL-1β
antibody. Actin in the same samples was detected by immunoblotting as a
loading control. Results shown in A–D are the average of three
independent experiments. Error bars represent standard deviation.
Statistical significance compared to YP-YopJKIM-infected
BMDMs in media alone was determined (ANOVA; P<0.01, **;
P<0.001, ***).
Determination of the effect of exogenous KCl on cytokine expression
and secretion in infected macrophages.
BMDMs were left uninfected (U) or infected at an MOI of 10 with
Yp-YopJKIM or Yp-YopJC172A and treated with 30
mM KCl (K+), 30 mM NaCl (Na+) or left untreated (Media) as
indicated. Supernatants were collected at 8 hr (A, B) or 24 hr (C, D)
post-infection, and secreted IL-1β (A, C) and TNF-α (B, D) were
measured by ELISA. (E) Pro-IL-1β in cell lysates prepared at 8 hr
post-infection was detected by immunoblotting with anti-IL-1β
antibody. Actin in the same samples was detected by immunoblotting as a
loading control. Results shown in A–D are the average of three
independent experiments. Error bars represent standard deviation.
Statistical significance compared to YP-YopJKIM-infected
BMDMs in media alone was determined (ANOVA; P<0.01, **;
P<0.001, ***).To examine how Y. pestis infection and KCl treatment affected
steady state levels of pro-IL-1β, lysates of macrophages left untreated or
treated with KCl or NaCl were prepared at 8 hr post-infection and analyzed by
immunoblotting for pro-IL-1β or actin as a loading control. As shown in
Figure 8E, infection
stimulated production of pro-IL-1β, with steady state levels of
pro-IL-1β slightly lower in macrophages infected with Yp-YopJKIM
as compared to Yp-YopJC172A (compare lanes 2 and 3, 5 and 6 and 8 and
9). Similar amounts of pro-IL-1β were detected in macrophages infected with
Yp-YopJKIM in the absence or presence of 30 mM KCl or 30 mM NaCl
(Figure 8E, compare lane
2 with 5 and 8). These results indicated that reduced detection of IL-1β in
supernatants of macrophages infected with YopJKIM and treated with
exogenous KCl was not due to KCl inhibiting production of pro-IL-1β.
Discussion
It was previously shown that caspase-1 was activated during YopJ-induced apoptosis of
macrophages infected with Y. pseudotuberculosis
[6]. In addition,
it was demonstrated that YopJKIM had increased capacity to cause
macrophage apoptosis and activate caspase-1 as compared to other YopJ isoforms [8]. However, the
mechanism of YopJ-induced caspase-1 activation and the molecular basis for enhanced
apoptosis and activation of caspase-1 in macrophages by YopJKIM was
unknown. The results of studies reported here indicate that several of the
requirements for YopJ-induced apoptosis and caspase-1 activation are the same, and
therefore it is likely that these two processes are mechanistically connected.
First, it is known that TLR4 signaling is important for YopJ-induced macrophage
apoptosis [21],
[22], [23], [24] and we
show here that the two major TLR adaptors, MyD88 and Trif, are important for
YopJ-induced caspase-1 activation. Second, desensitization of macrophages by
pretreatment with LPS decreases YopJ-induced apoptosis [38] and caspase-1 activation.
Third, comparison of the activities of different YopJ isoforms showed a direct
correlation between apoptosis, caspase-1 activation and inhibition of MAPK and
NF-κB signaling pathways. Forth, when macrophages in which
Ikkβ was conditionally deleted were infected with Y.
pestis, caspase-1 activation increased, providing genetic evidence that
IKKβ is an important target of YopJ for caspase-1 activation, as well as
apoptosis [25].Inhibition of MAPK and NF-κB pathways by YopJ is thought to reduce expression of
survival factors (e.g. FLIP, XIAP), thereby potentiating TLR4 signaling to trigger
apoptosis [22],
[23], [24].
Inactivation of the MAPK and NF-κB pathways by YopJ could also prevent
expression of putative negative regulators of caspase-1 (e.g. PAI-2) [7]. It is important
to point out that there is no direct evidence that PAI-2 inhibits caspase-1
activation independently of blocking apoptosis, rather the data show that PAI-2
overexpression reduces both apoptosis and caspase-1 activation [7]. It is possible that PAI-2
inhibits apoptosis and that events triggered downstream of TLR4-dependent programmed
cell death are required for caspase-1 activation. We suggest that caspase-1
activation is a normal outcome of a type of apoptosis that is triggered in
naïve macrophages by TLR4 signaling combined with pathogen interference with
MAPK and NF-κB pathways.Data presented here suggest that YopJKIM triggers increased apoptosis and
caspase-1 activation because it is a better inhibitor of macrophage survival
pathways than other YopJ isoforms. YopJKIM could function as a better
inhibitor of macrophage signaling pathways if it had a longer half-life in the host
cell, or had higher affinity for substrates. The F177L polymorphism could increase
protein stability, although it is not immediately clear why a Leu at position 177
rather than a Phe would increase protein half-life. The K206E mutation could
increase half-life, which is reasonable since Lys residues can be subject to
ubiquitination. Although not mutually exclusive of the preceding ideas, we favor the
hypothesis that the F177L and K206E substitutions allow YopJKIM to bind
more tightly to substrates, thereby making acetylation of targets more efficient at
limiting enzyme concentrations. We obtained two pieces of evidence supporting this
hypothesis. First, YopJKIM had higher apparent affinity for IKKβ than
YopJCO92 when these interactions were measured in cell lysates by a
GST pull down assay. Second, macrophages infected with Yp-YopJKIM had
lower levels of phosphorylated IκBα and MAPKs as compared to macrophages
infected with Yp-YopJCO92, indicating that there was increased inhibition
of IKKβ and MAPK kinase activity by Yp-YopJKIM.The results suggest a model whereby the canonical yopJ allele in
Y. pseudotuberculosis (yopJ)
was inherited by an ancestral Y. pestis strain, from which it
evolved to encode an isoform with higher apoptotic and caspase-1-activating
potential, YopJKIM, by the F177L mutation. The predicted sequence of a
YopJ protein in Y. pestis biovar 2.MED strain K1973002
(ZP_02318615) is identical to the sequence of YopJKIM, suggesting that
the phenotype observed is not an artifact resulting from a mutation acquired during
laboratory passage, but is associated with a unique yopJ genotype
associated with 2.MED strains. It is also hypothesize that the
yopJ allele evolved from
yopJ to encode an isoform with lower
cytotoxic and caspase-1 activating potential (YopJCO92) by the E206K
codon substitution. How these polymorphisms in YopJ affect Y.
pestis virulence and or the host response is not known but is an
important question to address in future studies.The importance of different inflammasome components for YopJ-dependent activation of
caspase-1 in macrophages infected with Y. pseudotuberculosis has
recently been examined [6]. This study showed that NLRP3 and ASC were not required
for activation of caspase-1 as measured by immunoblot analysis of caspase-1 cleavage
[6]. Those
results would appear to be in conflict with findings presented here showing a role
for NLRP3 and ASC in secretion of IL-1β and IL-18 from macrophages infected with
Yp-YopJKIM. However, recent studies suggest that multiple distinct
caspase-1 activation pathways with different biological outcomes can operate in
macrophages infected with a bacterial pathogen. For example, evidence has been
obtained that Legionella pneumophila stimulates two distinct
pathways of caspase-1 activation in macrophages [46]. ASC is required for secretion of
active IL-18 from L. pneumophila-infected macrophages, but is not
required for caspase-1 dependent induction of pyroptosis [46]. In addition, the multiplicity
and temporal stage of infection of macrophages with a bacterial pathogen can affect
the requirements for cell death and activation of caspase-1. Shigella
flexneri infection of macrophages at low MOI (<10) for short periods
of time induces NLRC4-dependent pyroptosis [47], [48], while infection at higher MOI
(50) for longer time periods induces NLRP3-dependent pyronecrosis [48]. Two different
infection procedures for examining YopJ-induced caspase-1 activation in macrophages
have been used in this study and previous publications [6], [8]. A high MOI (20) followed by 1 hr
of bacterial-host cell contact before addition of gentamicin results in detectable
YopJ-dependent apoptosis and caspase-1 activation within 2 hr of infection (Figure 5A, Figure S3 in Text S1) [6] but no
detectable secretion of IL-1β by this time point (data not shown) [6] . A low MOI
(10) followed by 20 min of bacterial-host cell contact before addition of gentamicin
results in detectable apoptosis and caspase-1 activation by 8–9 hr (Figure 5B,C) [8], at which time secreted IL-1β
and IL-18 are first detected [8]. High amounts of secreted IL-1β and IL-18 are detected
at 24 hr post infection under the low MOI procedure (e.g. Figure 2) [8]. The high and low MOI infection
procedures may result in different requirements for NLRs to activate caspase-1, as
shown by a requirement for ASC and NLRP3 in the latter but not former method.
Interestingly, the low MOI procedure appears to slow down the kinetics of apoptosis
and caspase-1 activation, which is likely important to allow for synthesis of NLRP3
[19] and
the pro-forms of IL-1β and IL-18.Under the low MOI conditions the presence of 30 mM KCl in the infection medium
inhibited the secretion of IL-1β and IL-18 from macrophages infected with
Yp-YopJKIM, suggesting an important role for K+
efflux in caspase-1 activation. Efflux of intracellular K+ mediated
by the P2X7R is critical for ATP-induced caspase-1 activation in
macrophages primed with LPS [49]. However, like other NLRP3 activators such as nigericin,
caspase-1 activation in response to Yp-YopJKIM infection did not require
P2X7R. One possibility is that pore formation during
YopJKIM-induced apoptosis leads to K+ efflux,
resulting in activation of the NALP3/ASC/caspase-1 inflammasome. One limitation of
this model is that it remains to be determined if K+ efflux acts as
a proximal activating signal of the NALP3/ASC/caspase-1 inflammasome. A second
limitation of this model is that apoptosis is generally associated with maintenance
of an intact plasma membrane, until late stages of cell death [4]. Future experiments will need to
address the possibility that YopJ-induced apoptosis of
Yersinia-infected macrophages can be associated with rapid membrane
permeability, resulting in K+ efflux and caspase-1 activation.
Materials and Methods
Ethics statement
All animal use procedures were conducted following the NIG Guide for the Care and
Use of Laboratory Animals and performed in accordance with Institutional
regulations after review and approval by the Institutional Animal Care and Use
Committee at Stony Brook University.
Yersinia strains, plasmids and growth conditions
Y. pestis and Y. pseudotuberculosis strains
used in this study are listed in Table S1 in Text S1.
Y. pestis strains used in this study are derived from KIM5
[8], which
lacks the pigmentation locus (pgm) and are exempt from select
agent guidelines and conditionally attenuated. Introduction of codon changes
into yopJ in KIM5 (Table S1 in Text S1)
was performed using the suicide plasmid pSB890 and allelic exchange as described
[50]. The
arabinose inducible plasmid encoding YopJKIM (pYopJ-GSK) has been
described [43]). Codon changes were introduced into
yopJ on this plasmid using Quikchange
(Invitrogen), yielding pYopJYPTB-GSK, pYopJKIME206K-GSK,
and pYopJCO92-GSK. The resulting plasmids were used to transform IP26
(IP2666 ΔyopJ) using electroporation and selection on LB
agar plates containing ampicillin (100 µg/ml) [8].
Bone marrow macrophage isolation and culture conditions
Bone marrow derived macrophages (BMDM) were isolated from the femurs of 6- to
8-week-old C57BL/6 female mice (Jackson Laboratories),
Casp-1mice [8], P2X7
receptor-deficient mice [51], Ikkβ or
Ikkβ mice [52], [53], NLRC4-
(Nlrc4-/-), ASC- (Asc-/-) or NLRP3-
(Nlrp3-/-) deficient mice [54], and MyD88-, Trif- and
MyD88/Trif-deficient mice [55] and cultured as previously described [56], [57].
Macrophage infections for LDH release, cytokine ELISA, IL-1β
immunoblotting and FLICA
Y. pestis cultures were grown overnight with aeration in HI
broth at 28°C. The next day the cultures were diluted to an OD600
of 0.1 in the same medium supplemented with 2.5 mM CaCl2 and
incubated for 2 hr at 37°C with aeration. Twenty-four hours before
infection, BMDM were seeded into wells of 24-well plates at a density of
1.5×105 cells/ml. Macrophage infections were performed in
37°C incubators with 5% CO2 at a multiplicity of infection
(MOI) of 10 as previously described [8]. After addition of bacteria,
plates were centrifuged for 5 minutes at 95 xg to induce contact between
bacteria and macrophages. After incubation at 37°C for 15 minutes,
macrophages were washed once with pre-warmed PBS to remove any bacteria that
have not been taken up. Fresh infection medium containing 8 µg/ml of
gentamicin was added for 1 hr at 37°C. After 1 hr, macrophages were washed
once with PBS and a lower concentration of gentamicin (4.5 µg/ml) in fresh
tissue culture media was added for the remaining incubation times. To inhibit
potassium efflux from infected macrophages, potassium chloride (KCl) was added
to a final concentration of 30 mM concurrently with the media exchanges
containing 8 µg/ml gentamicin and 4.5 µg/ml gentamicin [8]. Sodium
chloride (NaCl) was used as a control and added as above at a concentration of
30 mM above baseline. Amounts of IL-1β, TNF-α or IL-18 secreted into
tissue culture media during infection assays were measured by ELISA as described
[8].
Supernatants from infected macrophages were collected and analyzed for LDH
release as described [8]. Staining with
6-carboxyfluorescein–YVAD–fluoromethylketone (FAM-YVAD-FMK;
fluorescent inhibitor of apoptosis (FLICA)) (Immunochemistry Technologies) to
detect active caspase-1 in infected macrophages was performed using fluorescence
and phase microscopy as described [8] with the exception that the procedure was performed 9
hr post-infection, and the anti-Yersinia immunolabeling step
was omitted. Quantification of percent caspase-1 positive BMDMs was performed by
scoring macrophages for positive signal in three different randomly selected
fields (∼50–100 cells per field) on a coverslip.
Immunoblotting for pro-IL-1β
At 8 hr post-infection, macrophage lysates from triplicate wells were collected
in 100 µl of 1X lysis buffer (50 mM Tris-HCl, 5 mM EDTA, 150 mM NaCl,
1% Triton X-100, 2 mM DTT and a protease inhibitor cocktail
[Complete Mini, EDTA-Free, Roche]). Proteins were resolved by SDS-PAGE
and transferred to a nitrocellulose membrane. To detect IL-1β, membranes
were blotted with goat anti-IL-1β (R&D Systems). A secondary antibody,
Hamster anti-goat IRDye 700 antibody (Rockland) was used to detect samples, and
blots were viewed on the Odyssey Infrared Imaging System (LI-COR). To control
for loading, blots were probed with a rabbit anti-actin antibody
(Sigma-Aldrich).
Phospho-IκBα ELISA
BMDMs (106 cells per well) were seeded in 6-well plates. Y.
pestis cultures were grown as above and used to infect BMDM at a
MOI of 50. 1 hr post infection, cells were washed with ice-cold PBS and
incubated in 150 ul of 1X Lysis Buffer (Cell Signaling) for 5 min. Cells were
scraped on ice and sonicated twice for 5 seconds each. Lysates were centrifuged
at 4°C for 10 min and 100 µl of supernatant was used for ELISA.
Phospho-IκBα levels were determined using a PathScan
Phospho-IkappaB-alpha (Ser32) Sandwich ELISA kit according to
manufacturer's protocol (Cell Signaling).
Macrophage infections for Phospho-MAPK ELISA
BMDMs (106 cells per well) were seeded in 6-well plates. Y.
pestis cultures were grown in HI at 28°C overnight and diluted
1∶20 next day in the same medium supplemented with 20 mM NaOX and 20 mM
MgCl2. Cultures were shaken at 28°C for 1 hr and switched to 37°C for 2
hr. Cells were infected at an MOI of 20 and incubated for 30 or 60 min without
adding gentamicin. Macrophages were harvested and lysed as above. The PathScan
MAP Kinase Multi-Target Sandwich ELISA kit was used to determine phosphor-ERK,
-p38 and –JNK levels according to manufacturer's instruction (Cell
Signaling).
Macrophage infections for YopJ translocation and caspase-1 cleavage
assays
Y. pseudotuberculosis strains were grown in 2xYT at 26°C
overnight and diluted 1∶40 in the same medium supplemented with 20 mM
NaOX, and 20 mM MgCl2. Cultures were shaken at 26°C for 1 hr and
shifted to 37°C for 2 hr. BMDMs were seeded into wells of 6-well plates at a
density of 106 cells/well. Bacteria were harvested, washed with DMEM
and added to BMDMs at an MOI of 20. After 1 hr of infection gentamicin was added
to a final concentration of 100 µg/ml. To induce expression of YopJ-GSK
proteins, arabinose (0.2%) was maintained during grown in 2xYT at
37°C and in the cell culture medium used for infection. Y.
pestis strains were grown and used to infect macrophages as above
except that HI broth was used and arabinose was omitted. Two hr post-infection,
infected BMDMs were washed with PBS and lysed in buffer containing 50 mM
Tris-HCl pH 8.0, 5 mM EDTA, 2% Triton X-100, and 0.02% sodium
azide with protease inhibitors. In some experiments the macrophages were
incubated with 50 ng/ml of LPS for 3 hrs and then exposed to ATP at final
concentration of 2.5 mM for 1 hr as a positive control for caspase-1 cleavage.
Proteins were resolved by 10% SDS-PAGE, transferred to a PVDF membrane
and probed with anti-phospho-GSK-3β primary antibody (Cell Signaling). In
some experiments the blots were stripped and re-probed with rabbit polyclonal
anti-caspase-1 antibodies (Santa Cruz) or directly developed with this antibody.
As a loading control blots were reprobed with an anti-actin antibody
(Sigma-Aldrich, clone AC15). Goat anti-rabbit HRP conjugated secondary antibody
was used. Blots were detected with ECL reagent (Perkin Elmer Life Sciences,
Inc.).
GST pull down assay of YopJKIM-IKKβ interaction
Plasmids for expression of GST-YopJ fusion proteins were constructed from pLP16
[58]. The
pLP16 vector was derived from pGEX-2T and codes for YopJYPTB with an
N-terminal glutathione-S transferase (GST) affinity tag and a C-terminal M45
epitope tag. Quikchange mutagenesis (Invitrogen) was used to introduce codon
changes into pLP16 to generate pGEX-2T-YopJKIM,
pGEX-2T-YopJKIMC172A and pGEX-2T-YopJCO92, which
encode GST-YopJKIM, GST-YopJC172A and
GST-YopJCO92, respectively. The plasmids pGEX-2T,
pGEX-2T-YopJKIM, pGEX-2T-YopJKIMC172A and
pGEX-2T-YopJCO92 were used to transform E. coli
TUNER cells (Novagen). Cultures of TUNER cells harboring the above plasmids were
grown in LB at 37°C to OD600 of 0.2. IPTG was added to 0.1 mM final
concentration and cultures were grown at 18°C with shaking for 4 hrs. The
bacterial pellet obtained from 40 ml of each culture was resuspended in PBS
supplemented with protease inhibitor cocktail (Roche) and sonicated on ice. The
solubility of proteins in the sonicates was increased by incubation in the
presence of a buffer containing 10% sarkosyl at 4°C overnight [59]. After
centrifugation, the supernatant of the bacterial lysate was diluted 5 times with
a buffer containing 4% Triton X-100 and 40 mM CHAPS at final
concentrations. Thirty µl of glutathione beads (GST Bind Kit, Novagen)
were added and the mixture was shaken at 4°C for 1 hr. Beads were washed 4
times with 1 ml of GST Bind Kit buffer and used for pull down assays.Cell lysates containing overexpressed IKKβ were prepared from HEK293T cells
tranfected with a retroviral construct (pCLXSN-IKKβ-IRES-GFP) [25]. HEK293T
cells were seeded in 10 cm dishes and grown to reach 70% confluence. The
culture medium was replaced with serum free DMEM and the HEK293T cells in each
dish were transfected with 10 µg of pCLXSN-IKKβ-IRES-GFP using a
calcium phosphate method. Six hrs post transfection, the culture medium was
replaced with DMEM containing 10% FBS. Cells were harvested 48 hrs post
transfection, sonicated in PBS and centrifuged. Supernatants were stored at
−80°C until use.Beads containing bound GST proteins were incubated with 250 µl of cell
lysate supernatants from transfected HEK293T supernatant for 4 hrs at 4°C
with constant rotation. The beads were then washed 4 times with 1 ml of PBS each
and proteins bound to the beads were eluted in boiling 2X Laemmli sample buffer.
Samples of the eluates were subjected to SDS-PAGE and immunoblotting. Rabbit
polyclonal anti-IKKβ antibodies and mouse monoclonal anti-GST antibodies
were purchased from Cell Signaling and Santa Cruz, respectively. Immunoblot
signals representing IKKβ and GST or GST fusion proteins were quantified
using an Odyssey imaging system.
Statistical analysis
Experimental data analyzed for significance (GraphPad Prism 4.0) were performed
three independent times. Probability (P) values for multiple comparisons of
cytokine, phospho-IκBα ELISA and LDH release data were calculated by
one-way ANOVA and Tukey's multiple comparisons post-test. P values for two
group comparisons of cytokine, phospho-IκBα, and phospho-MAPK ELISA were
calculated by two-tailed paired student t test. P values were considered
significant if less than 0.05.The supporting text includes the supplemental Table S1, Figures S1-S7, and
supplemental experimental procedures.(DOC)Click here for additional data file.
Authors: Klaus Ruckdeschel; Gudrun Pfaffinger; Rudolf Haase; Andreas Sing; Heike Weighardt; Georg Häcker; Bernhard Holzmann; Jürgen Heesemann Journal: J Immunol Date: 2004-09-01 Impact factor: 5.422
Authors: Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov Journal: Cell Host Microbe Date: 2010-05-20 Impact factor: 21.023
Authors: Marianna Penzo; Raffaella Molteni; Tomomi Suda; Sylvia Samaniego; Angela Raucci; David M Habiel; Frederick Miller; Hui-Ping Jiang; Jun Li; Ruggero Pardi; Roberta Palumbo; Eleonora Olivotto; Richard R Kew; Marco E Bianchi; Kenneth B Marcu Journal: J Immunol Date: 2010-03-15 Impact factor: 5.422
Authors: Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem Journal: Nat Immunol Date: 2010-11-07 Impact factor: 25.606
Authors: Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz Journal: Infect Immun Date: 2020-02-20 Impact factor: 3.441
Authors: Mohammad Arifuzzaman; W X Gladys Ang; Hae Woong Choi; Matthew L Nilles; Ashley L St John; Soman N Abraham Journal: JCI Insight Date: 2018-09-20
Authors: David Yang-Wei Fann; Yun-An Lim; Yi-Lin Cheng; Ker-Zhing Lok; Prasad Chunduri; Sang-Ha Baik; Grant R Drummond; S Thameem Dheen; Christopher G Sobey; Dong-Gyu Jo; Christopher Li-Hsian Chen; Thiruma V Arumugam Journal: Mol Neurobiol Date: 2017-01-14 Impact factor: 5.590
Authors: Gregory I Vladimer; Dan Weng; Sara W Montminy Paquette; Sivapriya Kailasan Vanaja; Vijay A K Rathinam; Marie Hjelmseth Aune; Joseph E Conlon; Joseph J Burbage; Megan K Proulx; Qin Liu; George Reed; Joan C Mecsas; Yoichiro Iwakura; John Bertin; Jon D Goguen; Katherine A Fitzgerald; Egil Lien Journal: Immunity Date: 2012-07-27 Impact factor: 31.745